25357-95-3

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
1,3,5-Cyclohexanetricarboxylic acid is used as a precursor in the synthesis of various pharmaceuticals and agrochemicals for its ability to form complex molecules with therapeutic and pesticidal properties.
Used in Specialty Polymer Production:
1,3,5-CYCLOHEXANETRICARBOXYLIC ACID is utilized in the production of specialty polymers, where its tricarboxylic acid structure contributes to the polymer's unique properties and performance characteristics.
Used as a Chelating Agent in Coordination Chemistry:
1,3,5-Cyclohexanetricarboxylic acid functions as a chelating agent, enabling it to bind to metal ions and form stable complexes, which is valuable in coordination chemistry for various applications.
Used in Medical Applications:
Although not explicitly detailed in the provided materials, the compound's potential applications in the field of medicine suggest that it may be used in the development of treatments for certain diseases and disorders, likely due to its ability to form stable complexes and interact with biological systems.

InChI:InChI=1/C9H12O6/c10-7(11)4-1-5(8(12)13)3-6(2-4)9(14)15/h4-6H,1-3H2,(H,10,11)(H,12,13)(H,14,15)/t4-,5+,6-

Upstream product

• 554-95-0 benzene-1,3,5-tricarboxylic acid 

Downstream Products

• 1839-63-0 1,3,5-trimethylcyclohexane 
• 29305-31-5 cis-1,3,5-cyclohexanetricarbonyl trichloride 

Relevant academic research and scientific papers

Alicyclic carboxylic acid

PROBLEM TO BE SOLVED: To provide an unprecedentedly efficient method for manufacturing an alicyclic carboxylic acid by using a ruthenium-palladium co-supported catalyst as a catalyst for hydrogenating aromatic rings of aromatic carboxylic acids.SOLUTION:

Multivalent neuraminidase inhibitor conjugates

The invention relates to a multimeric compound or a pharmaceutically acceptable salt or derivative thereof which comprises three or more neuraminidase-binding groups attached to a spacer or linking group, in which the neuraminidase-binding group is a compound which binds to the active site of influenza virus neuraminidase, but is not cleaved by the neuraminidase. The invention also relates to processes for the preparation of the multimeric compound defined above, pharmaceutical compositions containing them or methods for the treatment and/or prophylaxis of a viral infection involving them.

Optically active phenoxypropionic esters

Optically active compounds of the formula I STR1 where R is C1 -C12 -alkyl or -perfluoroalkyl in which one or two non-adjacent CH2 or CF2 groups can also be replaced by --O-- and/or --CO-- and/or --CO--O-- and/or --CH=CH-- and/or --CH-halogen-- and/or --CHCN-- and/or --0--CO--CH-halogen-- and/or --O--CO--CHCN--, or is C1 -C12 -alkyl which can have a terminal chemically reactive group and in which a CH2 group can be replaced by --O--, A1 and A2 are each, independently of one another, 1,4-phenylene which is unsubstituted or substituted by one or two F and/or Cl and/or Br atoms and/or CH3 groups and/or CN groups and in which one or two CH groups can also be replaced by N, 1,4-cyclohexylene in which one or two non-adjacent CH2 groups can also be replaced by --O-- and/or --S--, 1,4-piperidinediyl, 1,4-bicyclo[2.2.2]octylene, 2,6-naphthalenediyl, decahydro-2,6-naphthalenediyl or 1,2,3,4-tetrahydro-2,6-naphthalenediyl, A3 is unsubstituted or substituted phenyl, Z is --CO--O--, --O--CO--, --CH2 CH2 --, --OCH2 --, --CH2 O--, --C C-- or a single bond and m is 0, 1, 2 or 3.